WASHINGTON, D.C. – U.S. Sen. Sherrod Brown (D-OH) today said Ohioans deserve a nominee to lead the Department of Health and Human Services (HHS) that will work to bring down the skyrocketing price of prescription drugs – not a former shill for the pharmaceutical industry like Alexander Azar, who the Finance Committee voted to advance today. Azar worked for drug company Eli Lilly for several years prior to his nomination, during which time Lilly increased the price of many products – including insulin – significantly. Brown voted against Azar’s confirmation, citing concerns over the price of prescription drugs and whether Azar would do right by Ohioans getting addiction treatment through Medicaid.
“Ohioans deserve a Health Secretary who’ll work with Congress to bring down the cost of prescription drugs and make health care better for all Americans – not a nominee who lined his pockets by raising costs on consumers. And as if his industry ties weren’t enough, he’s also done nothing to indicate that he’ll protect Medicaid, Ohio’s number one tool in the fight against opioids,” said Brown.